Newly diagnosed glioblastoma in the elderly: when is temozolomide alone enough?

Neuro Oncol. 2020 Aug 17;22(8):1058-1059. doi: 10.1093/neuonc/noaa136.
No abstract available

Keywords: MGMT; elderly; glioblastoma; methylation; radiotherapy; temozolomide.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Brain Neoplasms* / drug therapy
  • Brain Neoplasms* / genetics
  • DNA Methylation
  • DNA Modification Methylases / genetics
  • DNA Repair Enzymes / genetics
  • Dacarbazine / therapeutic use
  • Glioblastoma* / drug therapy
  • Glioblastoma* / genetics
  • Humans
  • Temozolomide* / therapeutic use

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • DNA Modification Methylases
  • DNA Repair Enzymes
  • Temozolomide